Have a feature idea you'd love to see implemented?
Let us know!
CRGX CARGO Therapeutics Inc
Price (delayed)
$15.73
Market cap
$724.02M
P/E Ratio
0.2
Dividend/share
N/A
EPS
$78.85
Enterprise value
$680.86M
We are a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients. Our programs, platform technologies, and manufacturing strategy are designed to directly
Highlights
The EPS has soared by 165% YoY and by 144% from the previous quarter
The company's quick ratio rose by 11% QoQ
The net income has dropped by 93% year-on-year and by 4.4% since the previous quarter
CARGO Therapeutics's equity has decreased by 8% from the previous quarter
Key stats
What are the main financial stats of CRGX
Market
Valuations
Earnings
Shares outstanding
46.03M
Market cap
$724.02M
Enterprise value
$680.86M
Price to book (P/B)
1.8
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$154.14M
EBITDA
-$147.33M
Free cash flow
-$140.05M
Per share
Balance sheet
Liquidity
EPS
$78.85
Free cash flow per share
-$2.94
Book value per share
$8.73
Revenue per share
$0
TBVPS
$9.46
Total assets
$450.96M
Total liabilities
$50.08M
Debt
$28.58M
Equity
$400.88M
Working capital
$388.38M
Debt to equity
0.07
Current ratio
18.95
Quick ratio
18.73
Net debt/EBITDA
0.29
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-33.9%
Return on equity
-38.2%
Return on invested capital
-54.9%
Return on capital employed
-35.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CRGX stock price
How has the CARGO Therapeutics stock price performed over time
Intraday
-0.57%
1 week
-7.47%
1 month
-24.95%
1 year
8.48%
YTD
-32.05%
QTD
-14.74%
Financial performance
How have CARGO Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$172.19M
Net income
-$154.14M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 137% YoY and by 12% from the previous quarter
The net income has dropped by 93% year-on-year and by 4.4% since the previous quarter
Growth
What is CARGO Therapeutics's growth rate over time
Valuation
What is CARGO Therapeutics stock price valuation
P/E
0.2
P/B
1.8
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 165% YoY and by 144% from the previous quarter
CRGX's P/B is 14% below its last 4 quarters average of 2.1
CARGO Therapeutics's equity has decreased by 8% from the previous quarter
Efficiency
How efficient is CARGO Therapeutics business performance
CARGO Therapeutics's ROA has soared by 65% YoY and by 17% from the previous quarter
CRGX's return on invested capital is up by 33% since the previous quarter
CARGO Therapeutics's ROE has increased by 29% from the previous quarter
Dividends
What is CRGX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CRGX.
Financial health
How did CARGO Therapeutics financials performed over time
CRGX's total liabilities is up by 20% YoY but it is down by 7% QoQ
CRGX's current ratio is up by 12% since the previous quarter
The debt is 93% smaller than the equity
The debt to equity has increased by 17% since the previous quarter
CARGO Therapeutics's equity has decreased by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.